Perceptive Advisors LLC Adverum Biotechnologies, Inc. Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $908,999 - $1.81 Million	-300,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $861,000 - $1.78 Million	300,000 New	300,000 $960,000
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $363,802 - $614,422	-80,845 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $295,084 - $642,717	80,845 New	80,845 $469,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.